Apellis Pharmaceuticals, Inc. (APLS)
40.87
+0.02
(+0.06%)
USD |
NASDAQ |
Apr 16, 16:00
40.88
+0.01
(+0.02%)
Pre-Market: 20:00
Apellis Pharmaceuticals Cash from Investing (Quarterly) : -0.108M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -1.232B |
| Eli Lilly & Co. | -2.802B |
| Agios Pharmaceuticals, Inc. | 90.08M |
| Scholar Rock Holding Corp. | 38.97M |
| BridgeBio Pharma, Inc. | -13.75M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.18M |
| Cash from Financing (Quarterly) | 1.259M |
| Free Cash Flow | 45.01M |
| Free Cash Flow Per Share (Quarterly) | -0.1128 |
| Free Cash Flow to Equity (Quarterly) | -13.27M |
| Free Cash Flow to Firm (Quarterly) | -3.379M |
| Free Cash Flow Yield | 0.87% |